Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial.
Study Goal
The researchers aimed to test the acceptability and preliminary efficacy of an exposure-based cognitive behavioral treatment incorporating mindfulness practice for adults with atopic dermatitis.
Results Summary
The study used an uncontrolled pretest-posttest design to evaluate the treatment, but specific efficacy results are not detailed in the abstract.
Population
Adults with atopic dermatitis (AD).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
exposure-based cognitive behavioral treatment (CBT) that entailed mindfulness practice | increase | tolerance for aversive experiences | adults with AD | - | increase tolerance for aversive experiences during exposure | #1 |
exposure-based cognitive behavioral treatment (CBT) that entailed mindfulness practice | neutral | treatment acceptability | adults with AD | - | test the treatment's acceptability | #2 |
exposure-based cognitive behavioral treatment (CBT) that entailed mindfulness practice | neutral | treatment preliminary efficacy | adults with AD | - | test the treatment's preliminary efficacy | #3 |
Atopic dermatitis (AD) is a common and debilitating inflammatory dermatological disorder and is marked by itch and inflamed skin. Scratching, sleep loss, and avoidance of situations associated with more AD symptoms are central hypothesized mechanisms that perpetuate the disorder and cause reduced quality of life. We developed an exposure-based cognitive behavioral treatment (CBT) that entailed mindfulness practice as a means to increase tolerance for aversive experiences during exposure. The aim of the present study was to test the treatment's acceptability and preliminary efficacy in adults with AD. We used an uncontrolled pretest-posttest design and recruited participants (